A five-fraction, one-week schedule of adjuvant breast radiotherapy is as safe and effective as a standard three-week schedule ...

Study authors examined the diagnostic utility of radiologic imaging for patients with high-risk cutaneous squamous cell carcinoma.

More information: PORTEC-4a; an international randomised trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer, Radiotherapy and Oncology (2025).

Discover a study that evaluated the effectiveness of hyperbaric oxygen therapy for radiation-induced dermatitis.

Depending on tumor location, presurgical radiation can improve overall survival, but that option comes with an increased risk ...

Agustí and colleagues conducted a cohort study to evaluate whether adjuvant chemoradiotherapy improved OS compared with radiotherapy alone in this patient population. They used prospectively ...

Patients not given adjuvant chemotherapy began radiotherapy within nine weeks after lumpectomy. For patients who received adjuvant chemotherapy, a delay of up to six months before irradiation was ...

Moreover, previous studies have suggested that more conservative options can be successfully used for low-risk, early-stage ...

Although, some studies with adjuvant and neoadjuvant radiotherapy showed improved local control and overall survival benefits in the 1970s and 1980s, they failed in other areas. Limitations of old ...

The international PORTEC-4a study offers strong evidence that molecular profiling can safely minimize radiotherapy in women ...

For women with high-intermediate risk disease, adjuvant radiotherapy — particularly vaginal brachytherapy (a form of internal radiotherapy delivered directly to the vaginal area) — is commonly ...

A patient with acute myeloid leukemia visited Atrium Health deeply concerned, but not about their disease.They had received a $50,000 bill and had no idea what to do about it. When physicians looked ...